Speaker

Phil Chamberlain

Co-Founder, President & Chief Executive Officer, Neomorph

Phil Chamberlain, Co-Founder, President & Chief Executive Officer at Neomorph, is speaking at 9th TPD & Induced Proximity Summit (Boston, United States of America, 26–29 Oct 2026) in the session “Panel Discussion: Shaping Investment in Induced Proximity: Insights to Accelerate Development & Secure Funding”.

Conferences: 1
Keynotes: 0
Upcoming: 1

Pharmacy & Pharmaceutical Sciences

Upcoming appearances

9th TPD & Induced Proximity Summit
26–29 Oct 2026Boston, United States of America
- PanelPanel Discussion: Shaping Investment in Induced Proximity: Insights to Accelerate Development & Secure FundingWith Adam Gilbert, Venkatesan Raghavan, Ryan Potts, Jason Kantor, Elena Diez, Carla Bauer, Artavazd Arumov

More speakers at 9th TPD & Induced Proximity Summit

Stuart Schreiber
Professor, Harvard Medical School
Randy Teel
President & Chief Executive Officer, Arvinas, Inc.
Alyn Davies
Associate Director, Medicinal Chemistry, AstraZeneca
Giovanni Spagnolli
Co-Founder & Chief Technology Officer, Sibylla Biotech srl
Nicki Thompson
Chief Executive Officer, Trimtech Therapeutics
Lauren Albrecht
Assistant Professor, University of California, Irvine

See all 54 speakers on the event page

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Phil Chamberlain, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].